Results of a Prospective Phase 2 Study of Pazopanib in Patients With Advanced Intermediate-Grade or High-Grade Liposarcoma
Cancer - United States
doi 10.1002/cncr.30926
Full Text
Open PDFAbstract
Available in full text
Date
August 18, 2017
Authors
Publisher
Wiley